SlideShare a Scribd company logo
SECONDARY HYPERTENSION
CAUSES AND DIAGNOSTIC APPROACH
WITH
MANAGEMENT OF HYPERTENSIVE EMERGENCY
BY : DR. RAJ KISHOR SINGH
JR-2, DEPT OF MEDICINE
HYPERTENSION
Current clinical criteria for defining hypertension generally are based on the
average of two or more seated blood pressure reading during each of
two or more out patient visits.
• A recent classification a/c to-AHA/2O17ACC recommend blood pressure
criteria for defining-
• Normal bp
• Elevated bp
• Stage 1 and stage 2 hypertension
*this classification slightly different from JNC7
• PRIMARY ESSENTIAL HPERTENSION;
TYPES
• SECONDARY HYPERTENSION
• It accounts for only 5-20% of hypertensive patients
• A specific underlying disorder causing the elevation of blood
pressure.
Essential hypertension is the term applied to the 80-95%of hypertensive
patients in which elevated blood pressure results from complex interaction
between multiple genetic and environmental factors
Causes of secondary hypertension
• Renal( most common cause)
• Renovascular
• Aortic coarctation
• Obstructive sleep apnea
• Preeclampsia/eclampsia
• Neurogenic-
psycogenic,polyneurits,acute increased intracranial
hypertension, acute spinal cord section
• Endocrine – Hypothyroidism,Hyperthyroidism,Hypercalcemia,Acromegaly
• Drugs/toxin-
High- dose estrogen,
Adrenal steroids,
cyclosporine,TCA,MAOi,Erythropoitin,NSAIDs
When to suspect secondary hypertension clinically?
•Absence of family history of hypertension
•Severe hypertension > 180/110 mm Hg with onset at age < 20 years or > 50 years
•Difficult-to-treat or resistant hypertension with significant end-organ damage feature
• Combination of pain (headache), palpitation, pallor and perspiration (phaeochromocytoma)
•Polyuria, nocturia, proteinuria or hematuria – indicative of renal disease
• Absence of peripheral pulses, brachiofemoral delay and abdominal or peripheral vessel bruits
•History of polycystic renal disease or palpable enlarged kidney
•Cushingoid features, multiple neurofibromatosis
•Significant elevation of serum creatinine with use of ACE inhibitors
•Hypertension in children
•History of snoring, daytime somnolence, obesity, short and thick neck – Obstructive Sleep Apnea
1. Renal parenchymal diseases
 Renal diseases is the most common causes of secondary hypertension.
 Secondary HTN is more severe in glomerular diseases than in interstitial diseases.
 Proteinuria >1000mg/day and an active urine sediments are indicator of PRIMARY
RENAL DISEASE
 CAUSES-
1. Glomerulonephritis
2. Pyelonephritis
3. Neprocalcinosis
4. Polycystic kidney disease
5. Neoplasm
6. Analgesic nephropathy
7. Gout with renal failure
8. Obstructive nephropathy
.
2. Renovascular hypertension
Renal artery stenosis is also a common cause of secondary hypertension with 2%
prevalence
The most common cause of renovascular hypertension in India is Takayasu’ disease –a
progressive aortoarteritis.
Takayasu’s disease is a non-specific pan arteritis affecting MOSTLY young women.
Hypertension is mainly due to renal artery stenosis which can be unilateral or bilateral
• The most common cause of renovascular disease in Western population are
atherosclerotic disease in 60% of elderly population and fibromuscular dysplasia in
35% of young
• Fibromuscular dysplasia sometimes produce total occlusion and can be associated
with renal artery aneurysm.
• Atherosclerotic disease cause the proximal segment renal artery stenosis and
fibromuscular dysplasia involves the distal segment of renal artery.
Takayasu arteritis of renal artery
Renal artery stenosis is more likely if-
• Hypertension is severe, of recent onset or difficult
to control
• Kidneys are asymmetrical in size
• Pulmonary edema occurs repeatedly
• Unexplained deterioration of renal function or detrition of
renal function on ACE inhibitor/ARB.
Diagnostic approach to renovascular hypertension
• A paraumbilical bruit is heard in 50-60% of patients with renovascular hypertension and 10%
cases of essential hypertension. A diastolic renal bruit is more specific than systolic bruit.
• Wherever there is a high degree of suspicion, direct selective renal arteriography is
recommended.
• Colour Doppler Ultrasound (CDUS), CT angiography and Gadolinium contrast-MRI angiography
are other good and non-invasive modalities. MRI angiography has higher sensitivity (90%) and
specificity (92%).
• 99Tc – DTPA and I-131 – orthoiodohippurate scan are useful non-invasive investigations.
• CONTRAST ARTERIOGRAPHY remains the gold standard for evaluation and identification of
renal artery lesion . Intra-arterial injection with digital subtraction angiography (DSA) may be
used.
3.Primary Aldosteronism
• Definition:Primary aldosteronism is due to excess aldosterone secretion by the
adrenal cortex ,secreted generally by adenomas and occasionally due to bilateral
adrenocortical hyperplasia.
• The prevalence varies from <2%- 15% of hypertensive individual. This is potentially
curable form of hypertension.
• In these pt. increased aldosterone production is independent of renin-angiotensin
system and the consequences are;
1) Sodium retention
2) Hypertension
3) Hypokalemia
4) Low Plasma renin activity(PRA)
• Generally diagnosed at age of 30 -50 years.
• Mostly asymptomatic ; however infrequently, headache, muscle
cramp,polyuria,polydipsia,paresthesias or muscle weakness may be present as
consequences of hypokalemic alkalosis. Hypertension usually mild-moderate but
occasionally may be severe.
• suspected in a case of hypertension showing persistent hypokalemic metabolic
alkalosis in the absence of diuretic therapy.
 Screening Test
a) Plasma Aldosterone to Plasma Renin Activity (PA/PRA) ratio >30:1 (normal < 10) is 90%
sensitive and 91% specific for Primary Hyper Aldosteronism.
b) Unprovoked hypokalemia(<3.1mmol/L)
.
Diagnosis
• Confirmed by –demonstrating failure to suppress plasma aldosterone to
<227pmol/L(<10ng/dl) after IV infusion of 2Lof isotonic saline over 4 hour.
• Alternatively confirmed by failure to suppress aldosterone in response to oral
NaCl load,fludrocortisone,or captopril.
 It is usually diagnosed by imaging techniques.
a) CT /HRCT if CT is not diagnostic, then we do
b) Adrenal scintigraphy with 6β-[I131] iodomethyl-19-norcholesterol after
dexamethasone suppression(0.5mg every 6hr for 7 days)
4. CUSHING’S SYNDROME
• Hypertension occurs in 75-80% of patients with Cushing syndrome.
• The mechanism may be related to stimulation of mineralocorticoid receptor by
cortisol and increased secretion of other adrenal steroids.
• This syndrome is related to excess cortisol production due to either ACTH
secretion (from pituitary tumor or an ectopic tumor) or
ACTH independent adrenal production of cortisol as well as
administration of exogenous glucocorticoid.
Cushing syndrome
Cushing syndrome : Diagnosis
Screening test;
• 24 hr. urine free cortisol :>90ug/day is 100%sensitive and 98% specific.
• Recent evidences suggests that late night salivary cortisol(>5nmol/L) is also
a sensitive and convenient screening test
Confirmatory test-
• Low dose dexamethasone suppression test – Give 1mg dexamethasone at
11 p.m. and draw a sample of blood at 8 a.m. for cortisol measurement
{>50nmol is +ve.}
• CT /MRI SCAN of head (pituitary) and chest (ectopic ACTH TUMOR)
5. PHEOCHROMOCYTOMA
• This is uncommon found in approximately 2 individuals per million
population.
• Pheochromocytoma is catecholamine secreting tumor of adrenal medulla
• Hypertension is primary related to increased circulating catecholamine
(norepinephrine,neuropeptide y) and other vasoactive substance but in few
cases epinephrine is main catecholamine which produce hypotension rather
than hypertension.
Pheochromocytoma
Essential of dignosis
• Attack of headache, profuse sweating, episode of palpitation (constitute classical
triad) sustained or paroxysmal hypertension ,anxiety and feeling of impending
doom
• Laboratory testing consists of measuring catecholamine in either using
a) 24 hr. urinary metanephrine excretion
b) Fractionated plasma free metanephrines.
• CT and MRI are both in similar sensitivity of imaging adrenal tumor
• while T2 weighted MRI with gadolinium contrast is better than CT in extra adrenal
tumor.
• MIBG labelled with I-131 is the most specific way of diagnosing adrenal and extra
adrenal pheochromocytomas and PET scan using 18-F flurodeoxyglucose(FDG) is
also useful.
6.Coarctation of aorta
• most common congenital cardiovascular cause of hypertension
• 35% of children is associated with Turner syndrome.
• Coarctaion of aorta consists of localized narrowing of aortic arch just distal to the
origin of the left subclavian artery.
Clinical presentation-
• differential systolic BP in arms and leg
• diminished/absent femoral artery pulse
• May be differential BP in arms if defect is proximal to left subclavian artery.
Diagnosis- may be confirmed by chest x-ray and trans esophageal
echocardiography.
Therapeutic options include surgical repair and balloon angioplasty.
Coarctation of aorta
Reason of differential BP Inferior rib notching
Miscellaneous cause of Secondary hypertension
Obstructive sleep apnea
The severity of hypertension correlates severity of sleep apnea. Diagnosis can be
confirmed by polysomnography.
Weight loss and administration of continuous positive airway pressure (CPAP) or bi-level
positive airway pressure(BiPAP) during sleep is an effective therapy.
Hypertension during pregnancy is usually caused by PreEclampsia Eclampsia , and gestational
hypertension.
OCP/ESTROGEN:A small increased in BP occurs in most women taking Estrogen or oral contraceptive.
This is caused by volume expansion due to increased angiotensinogen and consequent
activation of RAAS .
Thyroid disease- mild diastolic hypertension in hypothyroidism, where as hyperthyroidism causes
systolic hypertension.
Acute stressful situations cause intense sympathetic discharge and may temporarily induce
hypertension.
Common conditions include Hypoglycemia, exposure to cold, burns, perioperative period and post
head injury
Drugs: NSAID, sympathomimetic amines, glucocorticoids, cocaine and amphetamines can all cause
significant hypertension.
MANAGEMENT OF HYPERTENSIVE
EMERGENCY
What is hypertensive emergency?
• Hypertensive emergencies are abrupt, severe elevations in blood pressure,
in a patient with underlying hypertension or related to sudden onset
hypertension in previously normotensive individual.
• systolic blood pressure [SBP] greater than 180 mm Hg and/or
• diastolic blood pressure [DBP] greater than 120 mm Hg) associated with the
presence of target-organ dysfunction
Emergency includes ;
• Hypertensive encephalopathy(headache ,confusion, alter mental status)
• Hypertensive nephropathy(hematuria, proteinuria, and acute kidney injury)
• Progressive retinopathy
How Hypertensive emergency is different from urgency?
Hypertensive emergency
• Symptomatic severe hypertension
• Presence of acute end organ
damage
• BP reduced within minutes to
hour.
Hypertensive urgency
• Asymptomatic severe hypertension
• Absence of acute end organ damage
• BP reduced within a few hr.
Goal of therapy
Goal time BP Target
• First hour Reduce MAP(mean arterial pressure) by no more than 25%
• 2–24 hour maintain SBP 160 mm Hg and/or DBP 110 mm Hg
• 24–48 hour Outpatient BP goals according to the 2017 JNC
Guidelines for Management of High Blood Pressure.
Initially in Patients without encephalopathy or any catastrophic event, it is preferable to
reduce BP OVER an hour or longer with frequent dosing of short acting oral agent
such as
captopril, clonidine and Labetalol.
Excessive reduction of BP may precipitate Renal , coronary, cerebral ischemia.
A few hypertensive emergencies with preferred I.V DRUGS.
A)Hypertensive encephalopathy;
• I.V nitroprusside : short acting vasodilator with a rapid onset of action that allows for minute
to minute control of blood pressure.
• I.V Labetalol and Nicardipine are also effective agent.
B)Stroke- recommended drugs are – I.V NICARDIPINE, LABETALOL, NITROPRUSSIDE
a)Acute ischemic stroke :
In such cases antihypertensive should only be used if
SBP >220 mmhg or DBP >130 mmhg
If thrombolytic are to be given BP should be maintained at <185/110.
b) Hemorrhagic stroke : antihypertensive should be started if systolic
BP>180 mmhg ,or diastolic BP >130 mmhg.
c) subarachnoid hemorrhage - antihypertension management is controversial.
C)myocardial infarction /unstable angina –recommended iv drugs are – Nitroglycerin
Labetalol
Esmolol
D)acute left ventricular failure -drugs are- Nitroglycerin,
Enalprilate
Loop diuretics
E)Aortic dissection - Nitroprusside
Esmolol
Labetalol
f)Adrenergic crisis- PHENTOLAMINE,
Nitroprusside
g)Preeclampsia/eclampsia - Hydralazine ,
Labetalol
Usual intravenous dose of antihypertensive agent.
Labetalol
• 20 mg iv over 2 minute then 40-80 mg at every 10 min interval up to 300 mg total till
target BP is achieved.
• Total dose should not exceed 300 mg.
• 1-2 mg /min infusion till bp is achieved.
Nitroprusside
• Initial 0.3 µgm/kg/min to 10 µgm/kg/min. for every 10 min.
Nitroglycerin
• 5-20 µgm/min. in infusion ,then titrated by 5 µgm/min. at every 3-5 min. interval.
Secondary hypertension by dr Raj kishor

More Related Content

What's hot

RESISTANT HYPERTENSION
RESISTANT HYPERTENSIONRESISTANT HYPERTENSION
RESISTANT HYPERTENSION
Dr Siva subramaniyan
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
Manjunath Anvekar
 
Hypertension 2020 Updated Guidelines
Hypertension 2020 Updated GuidelinesHypertension 2020 Updated Guidelines
Hypertension 2020 Updated Guidelines
Dr. Aryan (Anish Dhakal)
 
hyponatremia
hyponatremiahyponatremia
Hypertensive Emergency
Hypertensive EmergencyHypertensive Emergency
Hypertensive Emergencydpark419
 
Primary hyperaldosteronism
Primary hyperaldosteronismPrimary hyperaldosteronism
Primary hyperaldosteronism
Abdulmoein AlAgha
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
Ashiqur Papel
 
Approach to secondary hypertension in young patients
Approach to secondary hypertension in young patientsApproach to secondary hypertension in young patients
Approach to secondary hypertension in young patients
Nilesh Jadhav
 
Upper GI Bleeding
Upper GI BleedingUpper GI Bleeding
Upper GI Bleeding
Hasnein Mohamedali MD
 
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And ManagementHepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Santosh Narayankar
 
Malignant hypertension
Malignant hypertensionMalignant hypertension
Malignant hypertension
Alaa Fadhel Hassan Alwazni
 
Current management of atrial fibrillation
Current management of atrial fibrillationCurrent management of atrial fibrillation
Current management of atrial fibrillation
Maame Ama Dodd-Glover
 
Hyperkalemia and its management
Hyperkalemia and its managementHyperkalemia and its management
Hyperkalemia and its management
MEEQAT HOSPITAL
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
Ahmed Abouelela
 
Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndromeFuad Farooq
 

What's hot (20)

RESISTANT HYPERTENSION
RESISTANT HYPERTENSIONRESISTANT HYPERTENSION
RESISTANT HYPERTENSION
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
 
Hypertension 2020 Updated Guidelines
Hypertension 2020 Updated GuidelinesHypertension 2020 Updated Guidelines
Hypertension 2020 Updated Guidelines
 
hyponatremia
hyponatremiahyponatremia
hyponatremia
 
Hypertensive Emergency
Hypertensive EmergencyHypertensive Emergency
Hypertensive Emergency
 
Atrial Fibrillation
Atrial FibrillationAtrial Fibrillation
Atrial Fibrillation
 
Primary hyperaldosteronism
Primary hyperaldosteronismPrimary hyperaldosteronism
Primary hyperaldosteronism
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Approach to secondary hypertension in young patients
Approach to secondary hypertension in young patientsApproach to secondary hypertension in young patients
Approach to secondary hypertension in young patients
 
Hyperosmolar hyperglycemic state
Hyperosmolar hyperglycemic stateHyperosmolar hyperglycemic state
Hyperosmolar hyperglycemic state
 
Minimal change disease
Minimal change diseaseMinimal change disease
Minimal change disease
 
Upper GI Bleeding
Upper GI BleedingUpper GI Bleeding
Upper GI Bleeding
 
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And ManagementHepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
 
Malignant hypertension
Malignant hypertensionMalignant hypertension
Malignant hypertension
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Current management of atrial fibrillation
Current management of atrial fibrillationCurrent management of atrial fibrillation
Current management of atrial fibrillation
 
Hyperkalemia and its management
Hyperkalemia and its managementHyperkalemia and its management
Hyperkalemia and its management
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndrome
 

Similar to Secondary hypertension by dr Raj kishor

Samir Rafla Principles of Cardiology pages 112 to end revised
Samir Rafla Principles of Cardiology pages 112 to end  revisedSamir Rafla Principles of Cardiology pages 112 to end  revised
Samir Rafla Principles of Cardiology pages 112 to end revised
Alexandria University, Egypt
 
Intracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaIntracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesia
DrManoj Tripathi
 
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdfadrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
mekuriatadesse
 
Pathophysiology of edema and its applied aspects
Pathophysiology of edema and its applied aspectsPathophysiology of edema and its applied aspects
Pathophysiology of edema and its applied aspects
SiddharthDash13
 
Adrenal mass
Adrenal massAdrenal mass
Adrenal mass
DR.Saad Alyousef
 
Adrenal gland disorders
Adrenal gland disordersAdrenal gland disorders
Adrenal gland disorders
Mohammed Dhamin Alareedh
 
HYPERTENSIVE CRISIS IN PEDIATRICS
HYPERTENSIVE CRISIS IN PEDIATRICSHYPERTENSIVE CRISIS IN PEDIATRICS
HYPERTENSIVE CRISIS IN PEDIATRICS
Tesfay Haile
 
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
Ankur Jain
 
Intracerebral hemorhage Diagnosis and management
Intracerebral hemorhage  Diagnosis and managementIntracerebral hemorhage  Diagnosis and management
Intracerebral hemorhage Diagnosis and management
Ramesh Babu
 
Intracerebral hemorhage Diagnosis and management
Intracerebral hemorhage  Diagnosis and managementIntracerebral hemorhage  Diagnosis and management
Intracerebral hemorhage Diagnosis and management
Ramesh Babu
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
Dr. Rohan Sonawane
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromePosterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndrome
NeurologyKota
 
Samir rafla principles of cardiology pages 112 to end
Samir rafla principles of cardiology pages 112 to endSamir rafla principles of cardiology pages 112 to end
Samir rafla principles of cardiology pages 112 to endAlexandria University, Egypt
 
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDCARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
Mohd Tariq Ali
 
Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]
Deepanshu Khanna
 

Similar to Secondary hypertension by dr Raj kishor (20)

Samir Rafla Principles of Cardiology pages 112 to end revised
Samir Rafla Principles of Cardiology pages 112 to end  revisedSamir Rafla Principles of Cardiology pages 112 to end  revised
Samir Rafla Principles of Cardiology pages 112 to end revised
 
Intracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaIntracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesia
 
Aneurysm
AneurysmAneurysm
Aneurysm
 
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdfadrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
adrenal gland hhhhhhhhhhhhhhhhhhhhhh.pdf
 
Hypertension evaluation 2
Hypertension   evaluation 2Hypertension   evaluation 2
Hypertension evaluation 2
 
Pathophysiology of edema and its applied aspects
Pathophysiology of edema and its applied aspectsPathophysiology of edema and its applied aspects
Pathophysiology of edema and its applied aspects
 
Adrenal mass
Adrenal massAdrenal mass
Adrenal mass
 
Pericarditis Postpericardiotomia
Pericarditis PostpericardiotomiaPericarditis Postpericardiotomia
Pericarditis Postpericardiotomia
 
Acute pulmonary thromboembolism
Acute pulmonary thromboembolismAcute pulmonary thromboembolism
Acute pulmonary thromboembolism
 
Adrenal gland disorders
Adrenal gland disordersAdrenal gland disorders
Adrenal gland disorders
 
HYPERTENSIVE CRISIS IN PEDIATRICS
HYPERTENSIVE CRISIS IN PEDIATRICSHYPERTENSIVE CRISIS IN PEDIATRICS
HYPERTENSIVE CRISIS IN PEDIATRICS
 
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
 
Intracerebral hemorhage Diagnosis and management
Intracerebral hemorhage  Diagnosis and managementIntracerebral hemorhage  Diagnosis and management
Intracerebral hemorhage Diagnosis and management
 
Intracerebral hemorhage Diagnosis and management
Intracerebral hemorhage  Diagnosis and managementIntracerebral hemorhage  Diagnosis and management
Intracerebral hemorhage Diagnosis and management
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathy
 
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromePosterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndrome
 
Samir rafla principles of cardiology pages 112 to end
Samir rafla principles of cardiology pages 112 to endSamir rafla principles of cardiology pages 112 to end
Samir rafla principles of cardiology pages 112 to end
 
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDCARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
 
Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]
 

Recently uploaded

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 

Recently uploaded (20)

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 

Secondary hypertension by dr Raj kishor

  • 1. SECONDARY HYPERTENSION CAUSES AND DIAGNOSTIC APPROACH WITH MANAGEMENT OF HYPERTENSIVE EMERGENCY BY : DR. RAJ KISHOR SINGH JR-2, DEPT OF MEDICINE
  • 2. HYPERTENSION Current clinical criteria for defining hypertension generally are based on the average of two or more seated blood pressure reading during each of two or more out patient visits. • A recent classification a/c to-AHA/2O17ACC recommend blood pressure criteria for defining- • Normal bp • Elevated bp • Stage 1 and stage 2 hypertension *this classification slightly different from JNC7
  • 3.
  • 4. • PRIMARY ESSENTIAL HPERTENSION; TYPES • SECONDARY HYPERTENSION • It accounts for only 5-20% of hypertensive patients • A specific underlying disorder causing the elevation of blood pressure. Essential hypertension is the term applied to the 80-95%of hypertensive patients in which elevated blood pressure results from complex interaction between multiple genetic and environmental factors
  • 5.
  • 6. Causes of secondary hypertension • Renal( most common cause) • Renovascular • Aortic coarctation • Obstructive sleep apnea • Preeclampsia/eclampsia • Neurogenic- psycogenic,polyneurits,acute increased intracranial hypertension, acute spinal cord section • Endocrine – Hypothyroidism,Hyperthyroidism,Hypercalcemia,Acromegaly • Drugs/toxin- High- dose estrogen, Adrenal steroids, cyclosporine,TCA,MAOi,Erythropoitin,NSAIDs
  • 7. When to suspect secondary hypertension clinically? •Absence of family history of hypertension •Severe hypertension > 180/110 mm Hg with onset at age < 20 years or > 50 years •Difficult-to-treat or resistant hypertension with significant end-organ damage feature • Combination of pain (headache), palpitation, pallor and perspiration (phaeochromocytoma) •Polyuria, nocturia, proteinuria or hematuria – indicative of renal disease • Absence of peripheral pulses, brachiofemoral delay and abdominal or peripheral vessel bruits •History of polycystic renal disease or palpable enlarged kidney •Cushingoid features, multiple neurofibromatosis •Significant elevation of serum creatinine with use of ACE inhibitors •Hypertension in children •History of snoring, daytime somnolence, obesity, short and thick neck – Obstructive Sleep Apnea
  • 8. 1. Renal parenchymal diseases  Renal diseases is the most common causes of secondary hypertension.  Secondary HTN is more severe in glomerular diseases than in interstitial diseases.  Proteinuria >1000mg/day and an active urine sediments are indicator of PRIMARY RENAL DISEASE  CAUSES- 1. Glomerulonephritis 2. Pyelonephritis 3. Neprocalcinosis 4. Polycystic kidney disease 5. Neoplasm 6. Analgesic nephropathy 7. Gout with renal failure 8. Obstructive nephropathy .
  • 9. 2. Renovascular hypertension Renal artery stenosis is also a common cause of secondary hypertension with 2% prevalence The most common cause of renovascular hypertension in India is Takayasu’ disease –a progressive aortoarteritis. Takayasu’s disease is a non-specific pan arteritis affecting MOSTLY young women. Hypertension is mainly due to renal artery stenosis which can be unilateral or bilateral • The most common cause of renovascular disease in Western population are atherosclerotic disease in 60% of elderly population and fibromuscular dysplasia in 35% of young • Fibromuscular dysplasia sometimes produce total occlusion and can be associated with renal artery aneurysm. • Atherosclerotic disease cause the proximal segment renal artery stenosis and fibromuscular dysplasia involves the distal segment of renal artery.
  • 10. Takayasu arteritis of renal artery
  • 11. Renal artery stenosis is more likely if- • Hypertension is severe, of recent onset or difficult to control • Kidneys are asymmetrical in size • Pulmonary edema occurs repeatedly • Unexplained deterioration of renal function or detrition of renal function on ACE inhibitor/ARB. Diagnostic approach to renovascular hypertension
  • 12. • A paraumbilical bruit is heard in 50-60% of patients with renovascular hypertension and 10% cases of essential hypertension. A diastolic renal bruit is more specific than systolic bruit. • Wherever there is a high degree of suspicion, direct selective renal arteriography is recommended. • Colour Doppler Ultrasound (CDUS), CT angiography and Gadolinium contrast-MRI angiography are other good and non-invasive modalities. MRI angiography has higher sensitivity (90%) and specificity (92%). • 99Tc – DTPA and I-131 – orthoiodohippurate scan are useful non-invasive investigations. • CONTRAST ARTERIOGRAPHY remains the gold standard for evaluation and identification of renal artery lesion . Intra-arterial injection with digital subtraction angiography (DSA) may be used.
  • 13. 3.Primary Aldosteronism • Definition:Primary aldosteronism is due to excess aldosterone secretion by the adrenal cortex ,secreted generally by adenomas and occasionally due to bilateral adrenocortical hyperplasia. • The prevalence varies from <2%- 15% of hypertensive individual. This is potentially curable form of hypertension. • In these pt. increased aldosterone production is independent of renin-angiotensin system and the consequences are; 1) Sodium retention 2) Hypertension 3) Hypokalemia 4) Low Plasma renin activity(PRA)
  • 14. • Generally diagnosed at age of 30 -50 years. • Mostly asymptomatic ; however infrequently, headache, muscle cramp,polyuria,polydipsia,paresthesias or muscle weakness may be present as consequences of hypokalemic alkalosis. Hypertension usually mild-moderate but occasionally may be severe. • suspected in a case of hypertension showing persistent hypokalemic metabolic alkalosis in the absence of diuretic therapy.  Screening Test a) Plasma Aldosterone to Plasma Renin Activity (PA/PRA) ratio >30:1 (normal < 10) is 90% sensitive and 91% specific for Primary Hyper Aldosteronism. b) Unprovoked hypokalemia(<3.1mmol/L) .
  • 15. Diagnosis • Confirmed by –demonstrating failure to suppress plasma aldosterone to <227pmol/L(<10ng/dl) after IV infusion of 2Lof isotonic saline over 4 hour. • Alternatively confirmed by failure to suppress aldosterone in response to oral NaCl load,fludrocortisone,or captopril.  It is usually diagnosed by imaging techniques. a) CT /HRCT if CT is not diagnostic, then we do b) Adrenal scintigraphy with 6β-[I131] iodomethyl-19-norcholesterol after dexamethasone suppression(0.5mg every 6hr for 7 days)
  • 16. 4. CUSHING’S SYNDROME • Hypertension occurs in 75-80% of patients with Cushing syndrome. • The mechanism may be related to stimulation of mineralocorticoid receptor by cortisol and increased secretion of other adrenal steroids. • This syndrome is related to excess cortisol production due to either ACTH secretion (from pituitary tumor or an ectopic tumor) or ACTH independent adrenal production of cortisol as well as administration of exogenous glucocorticoid.
  • 18. Cushing syndrome : Diagnosis Screening test; • 24 hr. urine free cortisol :>90ug/day is 100%sensitive and 98% specific. • Recent evidences suggests that late night salivary cortisol(>5nmol/L) is also a sensitive and convenient screening test Confirmatory test- • Low dose dexamethasone suppression test – Give 1mg dexamethasone at 11 p.m. and draw a sample of blood at 8 a.m. for cortisol measurement {>50nmol is +ve.} • CT /MRI SCAN of head (pituitary) and chest (ectopic ACTH TUMOR)
  • 19. 5. PHEOCHROMOCYTOMA • This is uncommon found in approximately 2 individuals per million population. • Pheochromocytoma is catecholamine secreting tumor of adrenal medulla • Hypertension is primary related to increased circulating catecholamine (norepinephrine,neuropeptide y) and other vasoactive substance but in few cases epinephrine is main catecholamine which produce hypotension rather than hypertension.
  • 20. Pheochromocytoma Essential of dignosis • Attack of headache, profuse sweating, episode of palpitation (constitute classical triad) sustained or paroxysmal hypertension ,anxiety and feeling of impending doom • Laboratory testing consists of measuring catecholamine in either using a) 24 hr. urinary metanephrine excretion b) Fractionated plasma free metanephrines. • CT and MRI are both in similar sensitivity of imaging adrenal tumor • while T2 weighted MRI with gadolinium contrast is better than CT in extra adrenal tumor. • MIBG labelled with I-131 is the most specific way of diagnosing adrenal and extra adrenal pheochromocytomas and PET scan using 18-F flurodeoxyglucose(FDG) is also useful.
  • 21. 6.Coarctation of aorta • most common congenital cardiovascular cause of hypertension • 35% of children is associated with Turner syndrome. • Coarctaion of aorta consists of localized narrowing of aortic arch just distal to the origin of the left subclavian artery. Clinical presentation- • differential systolic BP in arms and leg • diminished/absent femoral artery pulse • May be differential BP in arms if defect is proximal to left subclavian artery. Diagnosis- may be confirmed by chest x-ray and trans esophageal echocardiography. Therapeutic options include surgical repair and balloon angioplasty.
  • 22. Coarctation of aorta Reason of differential BP Inferior rib notching
  • 23. Miscellaneous cause of Secondary hypertension Obstructive sleep apnea The severity of hypertension correlates severity of sleep apnea. Diagnosis can be confirmed by polysomnography. Weight loss and administration of continuous positive airway pressure (CPAP) or bi-level positive airway pressure(BiPAP) during sleep is an effective therapy. Hypertension during pregnancy is usually caused by PreEclampsia Eclampsia , and gestational hypertension. OCP/ESTROGEN:A small increased in BP occurs in most women taking Estrogen or oral contraceptive. This is caused by volume expansion due to increased angiotensinogen and consequent activation of RAAS . Thyroid disease- mild diastolic hypertension in hypothyroidism, where as hyperthyroidism causes systolic hypertension. Acute stressful situations cause intense sympathetic discharge and may temporarily induce hypertension. Common conditions include Hypoglycemia, exposure to cold, burns, perioperative period and post head injury Drugs: NSAID, sympathomimetic amines, glucocorticoids, cocaine and amphetamines can all cause significant hypertension.
  • 25. What is hypertensive emergency? • Hypertensive emergencies are abrupt, severe elevations in blood pressure, in a patient with underlying hypertension or related to sudden onset hypertension in previously normotensive individual. • systolic blood pressure [SBP] greater than 180 mm Hg and/or • diastolic blood pressure [DBP] greater than 120 mm Hg) associated with the presence of target-organ dysfunction Emergency includes ; • Hypertensive encephalopathy(headache ,confusion, alter mental status) • Hypertensive nephropathy(hematuria, proteinuria, and acute kidney injury) • Progressive retinopathy
  • 26. How Hypertensive emergency is different from urgency? Hypertensive emergency • Symptomatic severe hypertension • Presence of acute end organ damage • BP reduced within minutes to hour. Hypertensive urgency • Asymptomatic severe hypertension • Absence of acute end organ damage • BP reduced within a few hr.
  • 27. Goal of therapy Goal time BP Target • First hour Reduce MAP(mean arterial pressure) by no more than 25% • 2–24 hour maintain SBP 160 mm Hg and/or DBP 110 mm Hg • 24–48 hour Outpatient BP goals according to the 2017 JNC Guidelines for Management of High Blood Pressure. Initially in Patients without encephalopathy or any catastrophic event, it is preferable to reduce BP OVER an hour or longer with frequent dosing of short acting oral agent such as captopril, clonidine and Labetalol. Excessive reduction of BP may precipitate Renal , coronary, cerebral ischemia.
  • 28. A few hypertensive emergencies with preferred I.V DRUGS. A)Hypertensive encephalopathy; • I.V nitroprusside : short acting vasodilator with a rapid onset of action that allows for minute to minute control of blood pressure. • I.V Labetalol and Nicardipine are also effective agent. B)Stroke- recommended drugs are – I.V NICARDIPINE, LABETALOL, NITROPRUSSIDE a)Acute ischemic stroke : In such cases antihypertensive should only be used if SBP >220 mmhg or DBP >130 mmhg If thrombolytic are to be given BP should be maintained at <185/110. b) Hemorrhagic stroke : antihypertensive should be started if systolic BP>180 mmhg ,or diastolic BP >130 mmhg. c) subarachnoid hemorrhage - antihypertension management is controversial.
  • 29. C)myocardial infarction /unstable angina –recommended iv drugs are – Nitroglycerin Labetalol Esmolol D)acute left ventricular failure -drugs are- Nitroglycerin, Enalprilate Loop diuretics E)Aortic dissection - Nitroprusside Esmolol Labetalol f)Adrenergic crisis- PHENTOLAMINE, Nitroprusside g)Preeclampsia/eclampsia - Hydralazine , Labetalol
  • 30. Usual intravenous dose of antihypertensive agent. Labetalol • 20 mg iv over 2 minute then 40-80 mg at every 10 min interval up to 300 mg total till target BP is achieved. • Total dose should not exceed 300 mg. • 1-2 mg /min infusion till bp is achieved. Nitroprusside • Initial 0.3 µgm/kg/min to 10 µgm/kg/min. for every 10 min. Nitroglycerin • 5-20 µgm/min. in infusion ,then titrated by 5 µgm/min. at every 3-5 min. interval.